Edoxaban Clinical Research Program

The randomized controlled trials

Clinical Setting Primary Completion
Non valvular atrial fibrillation

Presented at AHA 2013

NCT00781391

VTE & PE

Presented at ESC 2013

NCT00986154

Cardioversion

Presented at ESC 2016

NCT02072434

PCI

ongoing

NCT02866175

Cardiac ablation

ongoing

NCT02942576

Transcatheter aortic valve implantation ongoing

NCT02943785

80 years or older who are ineligible for current OAC therapy ongoing

NCT02801669

VTE associated with cancer

ongoing

NCT02073682

Non-interventional studies and registries

Non-interventional study Registry
Edoxaban Treatment in routiNe clinical prActice in Patients with non-valvular Atrial Fibrillation

DRKS00007912

UMIN000017011

Prolongation PREFER in AF PREvention oF thromboembolic events-European Registry in Atrial Fibrillation

DRKS00005996

Edoxaban Treatment in routiNe clinical prActice in Patients with Venous ThromboEmbolism

DRKS00007934

UMIN000024006

All Nippon AF In Elderly registry in Japan to study NVAF in elderly patients aged 75 years and older

UMIN000016387

Edoxaban Management In diagnostic and Therapeutic procedures - AF/VTE

NCT02950168

Venous Thromboembolism (VTE) in Cancer Patients;a Multicenter Prospective Registry

UMIN000024942

Global Vision and Mission

Pharmaceutical innovation and therapeutic advances have had a dramatic impact on the ...